Quick Answer
ENDRA Life Sciences Inc. reported Net Income of -$7.03 million for fiscal year 2025.
ENDRA Life Sciences Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$7.03M | +38.9% |
| 2024 | -$11.51M | -14.4% |
| 2023 | -$10.06M | +23.7% |
| 2022 | -$13.18M | -17.3% |
| 2021 | -$11.23M | +4.2% |
| 2020 | -$11.73M | +11.9% |
| 2019 | -$13.31M | -35.8% |
| 2018 | -$9.80M | -82.2% |
| 2017 | -$5.38M | -93.7% |
| 2016 | -$2.78M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.60M | +32.2% | -30.2% |
| June 30, 2025 | -$1.23M | +45.0% | -18.3% |
| March 31, 2025 | -$1.04M | +62.7% | +56.0% |
| September 30, 2024 | -$2.35M | +24.1% | -5.6% |
| June 30, 2024 | -$2.23M | +12.8% | +19.7% |
| March 31, 2024 | -$2.78M | +5.7% | +10.5% |
| September 30, 2023 | -$3.10M | +9.9% | -21.3% |
| June 30, 2023 | -$2.56M | +28.8% | +13.1% |
- ENDRA Life Sciences Inc. showed an increase of +38.9% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, ENDRA Life Sciences Inc.’s net income has declined by 153.2% (from -$2.78 million to -$7.03 million).
- The most recent figure is from ENDRA Life Sciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: